Matthew Korenberg - 15 Feb 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
President & COO
Signature
/s/ Andrew Reardon, Attorney-in-Fact for Matthew E. Korenberg
Issuer symbol
LGND
Transactions as of
15 Feb 2023
Transactions value $
-$210,912
Form type
4
Filing time
17 Feb 2023, 18:23:56 UTC
Previous filing
30 Dec 2022
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$210,912 -2,890 -3.12% $72.98 89,679 15 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.